Lexi Ventures
Status
ACTIVE
Global HQ
Menlo Park, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
Industries
- Fintech
- AI
- Health Tech
About
Lexi Ventures is an investment firm focused on the next great technology revolution. They invest in a balanced portfolio that includes therapeutics, diagnostics, food, materials, software, and more. They are committed to effective philanthropy and believe that investing is the most effective way to achieve it. Their notable investments include Taxa Technologies, Syntensor, Glyphic Biotechnologies, and ParcelBio.
Lexi Ventures is an investment firm focused on the next great technology revolution. They invest in a balanced portfolio that includes therapeutics, diagnostics, food, materials, software, and more. They are committed to effective philanthropy and believe that investing is the most effective way to achieve it. Their notable investments include Taxa Technologies, Syntensor, Glyphic Biotechnologies, and ParcelBio.
Investment Thesis
They invest in Seed stage US companies applying genomics, genetic engineering, or synbio to health and other industries such as food/ag, waste/recycling, and biomaterials. In general, startups working on DNA, RNA, proteins, and omics.
Manager's Experience
With a robust background in venture capital, the fund manager has actively invested in over 40 deals, primarily targeting early-stage technology startups across North America and Europe. Emphasizing a data-driven approach, they have successfully exited several high-profile investments, showcasing a keen ability to identify and nurture innovative solutions. The strategic focus spans key sectors such as fintech, healthtech, and sustainable energy, reflecting a commitment to thematic investing. Their operator-first philosophy leverages deep industry insights to guide portfolio companies towards scalable growth.